End-to-end advisory services for pharmaceutical companies navigating the evolving digital health landscape
Comprehensive advisory services that bridge the gap between innovation and market success
Identifying promising market opportunities and developing targeted go-to-market strategies through competitive analysis and value proposition creation
Strategic guidance through FDA approval processes, with experience submitting 10+ studies to the FDA, including via accelerated pathways like Breakthrough Device Designation
Developing pricing models, channel strategies, and sales tools to drive adoption across healthcare buyer segments
Crafting tailored propositions that resonate with health systems, payers, and pharma stakeholders
"Decimal's invaluable support enabled us to navigate the complex regulatory landscape, resulting in successfully receiving Breakthrough Device Designation from the FDA"
Ready to accelerate your digital health innovation? Let's start a conversation about how we can help.
Schedule a Consultation